Scientists at the Gladstone Institute of Virology and Immunology have discovered the mechanism that enables some CD4 T cells -- the main target of HIV -- to thwart the virus.

A six-year study of a special type of brain aneurysm -- the thrombotic aneurysm -- has led to a treatment "roadmap" that should mean better outcomes for patients with this unusual medical problem.

J. David Gladstone Institutes President Robert W. Mahley announced the appointment of Deepak Srivastava as the new director of the Gladstone Institute of Cardiovascular Disease (GICD).

People with "mild persistent asthma" -- about a quarter of all asthma sufferers -- appear to gain adequate relief by inhaling anti-inflammatory steroids only during periods of bad symptoms, rather than daily as current guidelines recommend, a new study shows

Up to 75 percent of fetal heart defects go undetected in routine ultrasound screening. UCSF researcher Lisa Hornberger teaches doctors better techniques to improve detection rates, and is working to treat heart defects before babies are born.

The Hereditary Disease Foundation has named Steven Finkbeiner, MD, PhD, an assistant investigator at the Gladstone Institute of Neurological Disease and assistant professor of neurology and physiology at UCSF, as the recipient of its highly esteemed Lieberman Award.

UCSF's Mission Bay campus is now headquarters for a new center to advance research on membrane proteins – proteins that are on the outside surface of cells and are the targets of nearly half of all drugs.

J. David Gladstone Institutes President Robert W. Mahley, MD, PhD, today announced the appointment of Deepak Srivastava, MD, as the new director of the Gladstone Institute of Cardiovascular Disease (GICD).

In honor of Women's Health Month in California, the UCSF National Center of Excellence in Women's Health will host community workshops in May on topics including aging, heart health and reproductive health. Workshops are free of charge and open to the public.